McGill University


Canada Health Greenlights Clinical Trial Investigating NuvOx’s Oxygen Therapeutic as a Treatment for COVID-19-based AHRF

NuvOX Pharma, a Tucson Arizona-based biotechnology company, received the green light in the form of a “No Objection Letter” form Health Canada to initiate a Phase 2a clinical trial investigating NanO2 in COVID-19 patients with acute hypoxic respiratory failure (AHRF)....

Pin It on Pinterest